New appointments at Idera Pharmaceuticals
This article was originally published in Scrip
Executive Summary
Idera Pharmaceuticals (US) has named Dr Robert Arbeit vice-president of clinical development and Dr Nicola La Monica vice-president of biology. Dr Arbeit was formerly vice-president of clinical development at Paratek Pharmaceuticals, while Dr La Monica most recently served as director of antiviral research at IRBM, a division of Merck Research Laboratories, in Rome. Idera has also promoted Dr Timothy Sullivan from vice-president of development programmes to vice-president of development programmes and alliance management.